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Background: Despite evidence that HIV positive women may suffer higher rates of heart disease, diabetes, human
papillomavirus infection, and some types of cancer, the provision of preventive health services to HIV positive women
is unknown. Preventive health services recommended for such women include breast, colorectal and cervical cancer
screening, sexually transmitted infection (STI) testing, vaccinations, and patient counseling on a number of issues
including sexual behaviors.
Methods: This retrospective cohort study utilized medical record reviews of 192 HIV positive women who were
patients at the University of Utah Infectious Diseases Clinic in 2009. Medical records were reviewed for all encounters
during 2009 using a standardized data collection form; data were collected on patient demographics and a variety of
preventive health services. Chi squared tests were used to assess receipt of preventive health services by demographic
factors, and multivariable logistic regression was used to determine predictors of receiving select services.
Results: The most commonly recorded preventive services included blood pressure screening, screening for Hepatitis A
and B, Tetanus-Diphtheria-Pertussis vaccination, Pneumococcal pneumonia vaccination, substance abuse screening, and
mental health screening. STI testing and safe sex counseling were documented in the medical records of only 37% and
33.9% of women, respectively. Documentation of cancer screening was also low, with cervical cancer screening
documented for 56.8% of women, mammography for 65% (N = 26/40) of women, and colorectal cancer screening for
10% (N = 4/40) of women, where indicated. In multivariable models, women with private health insurance were less likely
to have documented STI testing (OR 0.20; 95% CI 0.08 - 0.52), and, Hispanic women were less likely to have documented
safe-sex counseling (OR 0.26; 95% CI 0.07 - 0.94).
Conclusions: HIV/AIDS providers should focus on the needs of all women for preventive care services, including those
with fewer socio-demographic risk factors (i.e., insured, stable housing etc.). In addition, failure to provide STI testing,
cancer screening, or safe sex counseling to all patients represents a missed opportunity for provision of services
that are important from both a clinical and public health perspective.
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Since the advent of highly active anti-retroviral therapy
(HAART), the average life expectancy for HIV positive
individuals has increased, and patients with HIV are ex-
periencing lower rates of AIDS and AIDS-defining ill-
nesses. However, as the mortality directly associated
with HIV/AIDS has decreased, mortality rates from
non-HIV-related conditions such as cardiac disease and
non-AIDS-related cancers have increased [1]. While
rates of breast, colon, and prostate cancers are similar in
HIV positive and HIV negative individuals, rates of dys-
lipidemia and diabetes are higher among HIV positive
patients [1]. Additionally, many HAART drugs such as
protease inhibitors, are associated with increased risk for
certain comorbid conditions such as cardiovascular dis-
ease and diabetes [2,3]. As the HIV positive population
ages, it is important that clinicians provide routine, pre-
ventive health care and screening for conditions such as
colon cancer, hypertension, and dyslipidemia to these
patients [1,4].
In 2009, the HIV Medicine Association (HIVMA)
of the Infectious Diseases Society of America (IDSA)
announced new guidelines for providing preventive
healthcare for HIV positive individuals [5]. In accord-
ance with the United States Preventive Services Task
Force (USPSTF), the HIVMA recommends that all
HIV positive individuals age 50 and older have rou-
tine colorectal and breast cancer screening [6,7]. In
addition, STI testing is recommended annually for
syphilis, gonorrhea and chlamydia [6]. Regular patient
counseling is recommended regarding sexual behavior
and drug use as well as education about healthy diet,
weight reduction, smoking cessation, and seat belt use.
Lastly, many vaccinations are recommended for HIV
positive individuals, including inactivated annual influ-
enza vaccine [6].
HIV positive women have unique preventive health
care needs, including breast, colorectal, and cervical can-
cer screening, counseling about family planning and
contraceptive use, and pregnancy care, as applicable [4].
USPSTF and HIVMA guidelines include annual breast
and colorectal cancer screeing for women age 50 and
older and cervical cancer screening starting at age 21,
conducted annually if two normal Pap tests are docu-
mented during the first year after HIV diagnosis [6] and
the CD4 count is >200 cells/μL and increasing to every
6 months if the CD4 count is <200 cells/μL [8]. Atten-
tion to preventive health care in this population is
critical, as evidence suggests that they may be less likely
to receive breast cancer screening then their HIV nega-
tive peers, [9] are at greater risk for sexually transmitted
infections (STI), [10] and are more likely to be infected
with human papillomavirus (HPV) and to develop per-
sistent HPV infections [11]. It has been estimated thatas many as 60% of HIV positive women experience
co-infection with HPV [12]. HIV positive women are
at increased risk for cervical dysplasia, [13] and more se-
vere cervical cancer when compared to the general popu-
lation, with a lower average age at infection and a
considerably shorter developmental period [14]. HIV
positive women are also at higher risk for other comor-
bidities such as coronary heart disease and metabolic
syndrome, [15] diabetes and insulin resistance, [16] and
other cancers [17]. The high burden of comorbidities
among HIV positive women requires appropriate and
timely preventive health care.
Unfortunately, many factors serve as barriers to care
for HIV positive women, including socioeconomic and
structural barriers, poverty, cultural inequities, sexual
violence, physiologic differences, lack of awareness of
HIV status, and the ongoing stigma of being HIV posi-
tive [18]. HIV positive women are at increased risk for
social/emotional issues, [19] sexual violence, [20] trauma,
substance abuse and addiction, [19] homelessness, and
abuse [21]. Over half of HIV positive women report experi-
encing some form of intimate partner violence in adult-
hood [20]. In addition, HIV positive women report poorer
mental health than HIV negative women, [22] and HIV
positive women with depressive symptoms are more likely
to report frequent and severe abuse [23]. HIV positive
women who are racial/ethnic minorities are at especially
high risk for disparities in health care access and quality,
exacerbated by language and cultural barriers [18,24,25].
Non-English speaking women are less likely to receive
preventive services, [26] and although professional in-
terpreters improve the quality of care for such patients,
the use of interpreters in clinical settings is vastly under-
utilized [27-29]. Effective patient-provider communica-
tion is key to improving quality of care, [30] including
provision of recommended preventive services, but can
be a challenge. Barriers to effective patient-provider com-
munication among women with HIV, particularly racial/
ethnic minorities, may impact the quality of the prevent-
ive healthcare services they receive [31,32].
Despite improved accessibility to antiretroviral treat-
ments, and improved life expectancy among HIV posi-
tive women in care, little research has been done to
document the extent to which such women are receiving
appropriate preventive health care in accordance with
recommended guidelines. In this study, we conducted a
medical records review of all HIV positive women seen
in a Utah HIV/AIDS specialty clinic to describe the
demographic characteristics of these women, identify
gaps in the services they received, and evaluate predic-
tors of receipt of preventive health services. This review
was done in 2009 to correspond with the 2009 HIVMA/
IDSA guidelines for preventive healthcare for individuals
with HIV/AIDS.
Table 1 Demographics of HIV positive women seen at
Clinic 1A in 2009















Private insurance 61 31.8
Medicaid/Medicare 59 30.7
Primary Care Alliance (Ryan White Part C Program) 61 31.8
Other 10 5.2
Immigrant status5










HIV, not AIDS 100 52.1
AIDS 88 45.8
1Current age not recorded/missing for N = 2.
2Race not recorded/missing for N = 4.
3Ethnicity not recorded/missing for N = 6.
4Insurance status not recorded/missing for N = 1.
5Immigrant status not recorded/missing for N = 27.
6Primary language not recorded/missing for N = 5.
7Housing status not recorded/missing for N = 17.
8HIV/AIDS Status not recorded/missing for N = 4.
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Data collection & participants
This retrospective cohort study utilized medical record
reviews of HIV positive women who were patients at the
University of Utah Infectious Diseases Clinic (Clinic 1A)
in 2009. It is estimated that Clinic 1A serves an esti-
mated 70-80% of all HIV/AIDS patients in care in
Utah. Female patients comprised 16% of the clinic
population in 2009 and 13% of individuals with HIV/
AIDS in Utah [33]. Women seen in this clinic were
similar demographically to all HIV/AIDS patients in
Utah. All HIV positive women seen at least once at
Clinic 1A between January 1, 2009 and December 31, 2009
(n = 192) were included in the study. Data abstractors
used a standardized data collection form and entered
data using protocols developed through a consensus
process. Both electronic and paper medical records were
reviewed for specific information about patient demo-
graphics and health screenings (blood pressure, lipid
panel, cervical cancer screening, breast cancer screening,
colorectal cancer screening, mental health screening, and
substance abuse screening). Mammography and colorectal
cancer screening were indicated for women ages 50–75
(N = 40) in accordance with USPSTF guidelines. Medical
records were also reviewed for documentation of safe sex
counseling, vaccinations, sexually transmitted infection
(STI) testing, and tuberculosis (TB) testing. Complete
STI testing was defined as receipt of syphilis, gonorrhea,
and chlamydia screening. Housing status, obtained from
the medical record, was defined as stable, homeless, tran-
sient or subsidized. Lastly, the records were reviewed for
comorbidities listed in the patient’s “problem list”, medi-
cations used, adherence (missed visits, missed doses of
HAART), and referrals for eye exams, dental exams,
and case management. The study was approved by the
University of Utah Institutional Review Board.
Statistical analysis
Data were transferred into Stata 12.1 (College Station,
Texas) for data analysis. Descriptive statistics were cal-
culated to describe the demographic characteristics of
the women (Table 1) and the preventive health services
they received, with a focus on breast, cervical and colo-
rectal cancer screening; mental health and substance
abuse (including alcohol and drugs) screening; eye and
dental exam referral; STI testing including syphilis,
gonorrhea, and chlamydia; safe sex counseling; annual
influenza vaccination; and tuberculosis (TB) testing.
For bivariate analyses and multivariate regressions, we
created dichotomous variables for each of the prevent-
ive health services in Table 2 (services not received/not
recorded vs. service received). Because we were rarely
able to determine from the medical record when a ser-
vice was offered and declined (or not indicated) vs. notoffered, we combined these responses with the exception
of screenings indicated by age. For screenings indicated by
age, we limited analyses to women in the appropriate age
ranges. We used bivariate analyses to identify differences
in the receipt of preventive health services, including: cer-
vical cancer screening, mammography, STI testing, safe
sex counseling, influenza vaccination, TB testing, mental
Table 2 Receipt of preventive services among HIV positive
women seen at Clinic 1A in 20091




Not indicated4 5 2.6
Not recorded/missing 60 31.2
Mammogram among women age 50–75 (N = 40)3
Yes 26 65.0
No 2 5.0
Not indicated4 0 0
Not recorded/missing 12 30.0




Not indicated4 1 2.5




Not indicated4 0 0




Not indicated4 0 0




Not indicated4 0 0




Not indicated4 0 0




Not indicated4 0 0




Table 2 Receipt of preventive services among HIV positive
women seen at Clinic 1A in 20091 (Continued)
Not indicated4 0 0




Not indicated4 0 0
Not recorded/missing 103 53.7






Not indicated4 3 1.6




Not indicated4 0 0




Not indicated4 26 13.5
Not recorded/missing 41 21.3
1For bivariate analyses and multivariate regressions we created dichotomous
variables for each of the preventive health services in Table 2 (services not
received/not recorded/missing vs. service received).
2No age cut off for women who are immunocompromised (including HIV
positive) according to USPSTF recommendations.
3Excludes N = 152 participants who were outside of the USPSTF recommended
age range for mammogram and colorectal cancer screening (<50 years
or >75 years).
4Not indicated means the medical record has a note about a procedure not
being done and why it was not done.
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preventive health service was evaluated by: race, Hispanic
ethnicity, U.S. citizenship, housing status, insurance status,
and language. Chi-squared statistics were used to evaluate
the differences in screening behaviors by select demo-
graphic characteristics including race (White vs. Non-
White), ethnicity (Hispanic vs. Non-Hispanic), citizenship
(U.S. citizen vs. other), housing status (stable vs. other), in-
surance status (private vs. other), and language (English
vs. other). Finally, multivariable-adjusted odds ratios were
calculated for preventive health service variables with sig-
nificant between-group differences in more than one chi-
squared analysis. These included STI testing and safe sex
counseling. Covariates of interest in these models included
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ance, and language. All statistical tests were two sided, and




Table 1 displays select demographic characteristics of
the participants. There were 192 HIV positive women
seen in Clinic 1A in 2009. Of these, 52.1% had HIV and
45.8% had AIDS. Similar to the demographics of all
HIV/AIDS patients in Utah, the majority of women in
the study were Caucasian (68.2%) or of African descent
(24%). Over three quarters of women (75.5%) were non-
Hispanic and 61.5% were U.S. citizens. Countries of
origin included: Angola, Burma, Burundi, Congo,
Ethiopia, Ghana, Liberia, Rwanda, Sudan, South Africa,
Tanzania, Togo, Mexico, Argentina, El Salvador, Haiti,
Honduras, Venezuela Thailand, and Russia. Sixty-six
(34.4%) women reported a primary language other than
English. Languages included: Spanish, Bassa, Amharic,
Arabic, Gromo, Burmese, Ewe, French, Hatian, Italian,
Kingarwanda, Swahili, Linggla, Kirundi, Mali, Mende,
Vai, Pakistani, Portugese, Russian, Thai, Vietnamese, and
Zulu. The women had a variety of contextual and behav-
ioral risk factors, with only 31.8% reporting private health
insurance, 19.8% reporting being homeless or living in
transient or subsidized housing, 38.5% having a mental
health issue and 21% reporting substance abuse including
abuse of alcohol or drugs.
Receipt of preventive health services
The most commonly recorded preventive health services
received by HIV positive women included blood pressure
screening, screening for Hepatitis A and B, Tetanus-
Diphtheria-Pertussis vaccination, Pneumococcal pneumo-
nia vaccination, substance abuse screening, and mental
health screening. All of these preventive health services
were received by at least 75% of women (data not shown).
However, only 37% of women received complete STI test-
ing including syphilis, gonorrhea, and chlamydia testing,
and 33.9% had safe sex counseling documented in their
medical record during the last year. Additionally, 56.8% of
women received cervical cancer screening, 65% (N=26/40)
of women age 50 or older received a mammogram and
10% (N=4/40) of women age 50 or older received colorec-
tal cancer screening. Less than one-third of women re-
ceived a referral for a dental or eye exam. Data on select
preventive health services are shown in Table 2.
Factors related to receipt of preventive health services
Non-white women were significantly more likely to have
STI testing (p = 0.008) and safe sex counseling (p=0.001)
documented in their medical records, while Hispanicwomen, English speaking women, and those with U.S.
citizenship were less likely to have documented safe sex
counseling (p = 0.002, 0.017, and 0.004, respectively).
Women with private insurance were also less likely to have
documented STI testing (p < 0.001) or cervical cancer
screening (p = 0.025). However, women in stable housing
situations were more likely to have mental health screening
(p = 0.020), and substance abuse screening (p = 0.026) doc-
umented in their medical records (Table 3). No significant
differences in services were observed for women with sub-
stance abuse issues, comorbidities, or mental health issues
(data not shown).
In order to further understand the relationship between
Hispanic ethnicity, primary language, U.S. citizenship, and
receipt of safe sex counseling, additional analyses were
done (data not shown). Among English speakers, there
were no differences in the proportion of women who had
documented safe sex counseling between Hispanics and
non-Hispanics. Among non-English speakers, Hispanics
were much less likely than non-Hispanics to have safe sex
counseling documented (12% vs. 65.9%, p < 0.001). A simi-
lar pattern was observed when stratified by U.S. citizenship.
Among U.S. citizens, there were no significant differences
between the proportion of Hispanics and non-Hispanics
with documented safe sex counseling. Among non-
citizens, Hispanics were much less likely than non-
Hispanics to have safe sex counseling documented (8.3%
vs. 68.6%, p < 0.001).
Multivariable logistic regression models for receipt of STI
testing and safe sex counseling
Documented receipt of all three recommended STI tests
(syphilis, chlamydia, and gonorrhea) and documented
receipt of safe sex counseling was related to a number of
demographic factors among this patient population. Re-
sults of multivariable logistic regression models identify-
ing factors that may be independently related to receipt
of these services are shown in Table 4. We found that
having private insurance significantly decreased a pa-
tient’s likelihood of documented receipt of all three STI
tests in a multivariable logistic regression model that
included race, Hispanic ethnicity, immigration status,
housing status, health insurance status and language
(OR: 0.20; 95% CI: 0.08 - 0.52). Women of Hispanic eth-
nicity were less likely to have documented receipt of
safe sex counseling in a multi-variable logistic regres-
sion model that include race, immigration status, housing
status, insurance status and language (OR: 0.26; 95% CI:
0.07 - 0.94).
Discussion
Little is known about the provision of preventive health
services to HIV positive women receiving care in an
HIV/AIDS specialty clinic, despite evidence that such















p = p = p = p = p = p = p = p =
N % N % N % N % N % N % N % N %
Race 0.682 0.979 0.008 0.001 0.225 0.182 0.472 0.151
White 73 57.5 17 42.5 40 30.5 33 25.6 95 96.0 82 70.7 107 81.7 123 93.9
Non-white 34 60.7 9 42.9 29 50.9 31 55.4 40 90.9 38 80.9 49 86.0 50 87.7
Ethnicity 0.358 0.241 0.772 0.002 0.149 0.769 0.580 0.080
Hispanic 21 51.2 7 58.3 16 39.0 6 14.6 27 90.0 25 75.8 33 80.5 35 85.4
Non-Hispanic 83 59.3 19 39.6 53 36.6 57 40.1 108 96.4 93 73.2 122 84.1 136 93.8
Immigration
status 0.100 0.171 0.078 0.004 0.122 0.683 0.107 0.549
Citizen 61 54.0 13 36.1 38 32.2 35 30.2 82 96.5 78 73.6 96 81.4 111 94.1
All other 32 68.1 11 55.0 22 46.8 25 54.3 34 89.5 30 76.9 43 91.5 43 91.5
Housing status 0.649 0.200 0.675 0.121 0.153 0.575 0.020 0.026
Stable 81 60.9 20 47.6 15 39.5 53 39.0 104 92.9 87 73.7 119 86.9 130 94.9
All other 21 56.7 5 29.4 49 35.8 9 25.0 21 100.0 22 68.7 27 71.0 32 84.2
Insurance 0.025 0.437 <0.001 0.200 0.741 0.280 0.612 0.648
Private 27 46.5 13 48.1 10 16.4 25 41.0 44 93.6 36 67.9 52 85.2 57 93.4
All other 82 64.1 13 38.2 61 46.9 40 31.5 94 95.0 85 75.9 107 82.3 119 91.5
Language 0.565 0.773 0.047 0.017 0.452 0.667 0.081 0.127
English 67 57.8 17 44.7 39 32.2 34 28.6 86 95.6 80 74.1 96 79.3 114 94.2
All other 41 62.1 9 40.9 31 47.0 30 46.1 50 92.6 39 70.9 59 89.4 58 87.9
1Bold indicates significant at alpha level of 0.05.
2STI testing included receipt of syphilis, chlamydia, and gonorrhea testing vs. did not receive ≥1 of these tests.
Table 4 Adjusted multivariable logistic regression models
for receipt of STI testing and safe sex counseling1
STI testing2,3 Safe sex counseling3
OR 95% CI OR 95% CI
Race p = 0.256 p = 0.177
White .55 (.20-1.54) .48 (.17-1.39)
Ethnicity p = 0.428 p = 0.040
Hispanic .65 (.23-1.88) .26 (.07-.94)
Immigration status p = 0.854 p = 0.548
Citizen .89 (.24-3.22) 0.67 (.18-2.51)
Housing status p = 0.420 p = 0.134
Not stable 1.43 (.60-3.42) 2.12 (.79-5.68)
Insurance p = 0.001 p = 0.577
Private .20 (.08-.52) 1.26 (.56-2.83)
Language p = 0.724 p = 0.450
English .80 (.22-2.82) .59 (.15-2.28)
1Bold indicates significant at alpha level of 0.05.
2STI testing included received syphilis, chlamydia, and gonorrhea testing vs.
did not receive ≥1 of these tests.
3Adjusted for race, Hispanic, immigration status, housing status, insurance,
and language.
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disease, diabetes, HPV infection, and some types of can-
cer [11,12,14-17]. This study is among the first to evalu-
ate factors associated with receipt of preventive care
among such women. We found that among all HIV posi-
tive women seen for HIV/AIDS care in 2009 in an aca-
demic specialty clinic, there were wide variations in the
types of services they received. Notably, STI testing and
safe sex counseling were documented in the medical re-
cords of only 37% and 33.9% of women, respectively.
Documentation of cancer screening was also low, with
56.8% of women having documentation of cervical cancer
screening, 65% having documentation of mammography
where indicated, and only 10% having documentation of
colorectal cancer screening where indicated. In contrast,
in Utah in 2010, 71.8% of women age 50 and older re-
ceived a mammogram, [34] 74% received cervical cancer
screening, [35] and 66.3% received colorectal cancer
screening [36]. Of note, nearly a third of patients in this
study (31.8%) were covered solely through the Prevention
Care Alliance (Ryan White Part C Program). Due to lim-
ited resources, such patients are not routinely referred for
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majority of these patients do not have funds to cover the
out of pocket expenses associated with these services.
In the context of the preventive health services re-
ceived by this patient population, it is important to point
out that these patients are clinically challenging for sev-
eral reasons. More than one-third of the HIV positive
women in this study spoke a language other than
English, nearly 1 in 5 did not have stable housing ar-
rangements, and there were high rates of mental health
issues and substance abuse among them. These issues
make it challenging for clinicians to provide a full range
of preventive services during busy HIV/AIDS-related
clinic visits, as many these women have multiple issues
that need to be addressed in addition to their HIV/AIDS
care. However, these challenges are likely true for any
healthcare provider caring for HIV positive women and
are not unique to HIV positive women in Utah.
Interestingly, we found that racial minorities and non-
English speakers were more likely to receive some
types of preventive services than Caucasian or English-
speaking women. For example, we found that White
women, U.S. citizens, and English-speakers were less
likely to have safe sex counseling documented. White
women and those with private health insurance were less
likely to have STI testing documented. Women with pri-
vate insurance were also less likely to have cervical can-
cer screening documented. In multivariable models,
women with private health insurance were less likely to
have documented STI testing. These findings may be due
to several issues including the practices of specific pro-
viders who tend to care for different types of patients
(English vs. Spanish-speaking patients, for example). In
addition, the out-of-pocket expenses associated with
some of these services may require co-payments for
privately insured patients, but may be available at no
cost to publically insured patients. Finally, privately in-
sured patients may have primary health care providers
outside of the University of Utah system and may not
have preventive services received outside of the system
documented in their University medical records.
This study advances prior research by incorporating
data from a clinic which serves a large proportion of
HIV positive women in the state of Utah. Clinic 1-A is
the premier HIV-AIDS clinic in Utah, and captures the
majority of HIV positive women in the state. A thorough
chart audit process was used, including searching for lab
values (i.e. cervical cancer screening results) if they were
not included in the patient’s medical record. This
process provided accurate data about the provision of
preventive health services to all patients seen in the
clinic in 2009. As the HIVMA introduced new guide-
lines for preventive care of HIV positive individuals in
2009, these data can be used in future studies to explorechanges in providers’ recommendation and provision of
preventive services for this population.
There are several important limitations to the study.
The study clinic is not part of a closed health care sys-
tem, and it is possible that some patients may have had
primary care providers outside of the University of Utah
system. We were unable to query those records. In many
cases, the provision of clinical services was not docu-
mented at all. In these instances, we assumed that the
services were not provided. This may be an inaccurate
assumption, for example, in the case of safe-sex counseling,
which may be done conversationally but not recorded in
the medical record. We did not collect detailed informa-
tion on contraceptive methods (e.g., tubal, hormonal etc.)
as many women received these from other sources (OB/
GYNs, family planning clinics). Investigating the provision
of contraceptives to HIV positive women is an important
future research opportunity.
Lastly, at the time of this study, the clinic was using
primarily paper-based medical records, with some labs
and other results available electronically. Since that time,
the clinic has switched to exclusively electronic charting.
In the future, we hope to compare data on the provision
of preventive health services under the new electronic
medical record system to see if utilization of such a sys-
tem has helped improve reporting of the proportion of
women receiving recommended services.
When reviewed in the context of the HIVMA/IDSA
guidelines for the preventive care of HIV positive
women, patients in this study were less likely to have
received mammography, cervical cancer screening, or
colonoscopy then women in the general Utah population.
Receipt of colorectal cancer screening was notable low,
with only 1 in 10 patients receiving such screening. Re-
ceipt of STI testing and safe sex counseling were also
very low, with documentation in the medical records of
37% and 33.9% of patients, respectively. However, on a
positive note, rates of substance abuse screening were
high (91.7%) and nearly three quarters of women (71.9%)
received an annual influenza vaccine.
Conclusions
In 2009, the HIV Medicine Association (HIVMA) of the
Infectious Diseases Society of America (IDSA) recom-
mended HIV positive women receive routine, preventive
health care as a part of their regular HIV/AIDS care.
However, in an academic specialty HIV/AIDS clinic
serving a large proportion of the HIV positive women in
Utah, we found that the provision of many recom-
mended preventive services was lacking, particularly
among women with fewer socio-demographic risk fac-
tors (i.e., insured, White race, stable housing etc.). Our
findings serve as a reminder that HIV/AIDS providers
must focus on the needs of all women for preventive
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part of a vulnerable population. In addition, failure to
provide preventive services such as STI testing, cancer
screening, or safe sex counseling to all patients repre-
sents a missed opportunity for provision of services that
are important from both a clinical and public health per-
spective. Finally, given the longevity of HIV positive pa-
tients in the era of HAART and the extensive list of
recommended preventive health care services, the opti-
mal setting for the care of such patients may need to
shift away from infectious diseases specialty clinics to-
wards general medicine clinics with HIV/AIDS consul-
tants. As HIV/AIDS continues to evolve as a disease,
new health care models may be needed to address the
complex needs of patients including preventive health
care, mental health and substance abuse services, and
social services in addition to HIV/AIDS care.Consent
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